| 2006 |
SEC23A is an essential component of COPII-coated vesicles mediating ER-to-Golgi transport; the disease-causing F382L substitution results in loss of SEC23A function in cell-free vesicle budding assays, causing gross ER dilatation and cytoplasmic mislocalization of SEC31 in patient fibroblasts. |
Positional cloning, cell-free vesicle budding assay, electron microscopy, immunofluorescence, zebrafish morpholino knockdown |
Nature genetics |
High |
16980979
|
| 2006 |
Zebrafish sec23a loss-of-function (crusher nonsense mutation L402X) causes chondrocyte ER distension and failure to secrete type II collagen and other ECM proteins into cartilage extracellular matrix, establishing SEC23A as an integral COPII component required for ECM secretion in chondrocytes. |
Positional cloning, zebrafish genetic mutant analysis, immunofluorescence, electron microscopy; sec23b knockdown (morpholino) shows paralog is also required |
Nature genetics |
High |
16980978
|
| 2009 |
BBF2H7 (CREB3L2) directly binds a CRE-like sequence in the Sec23a promoter to activate its transcription in response to ER stress; introduction of Sec23a into Bbf2h7-/- chondrocytes fully restores impaired cartilage matrix protein transport and secretion, placing SEC23A downstream of BBF2H7 in ER stress-to-ER-Golgi trafficking signaling. |
Bbf2h7 knockout mouse generation, promoter binding assay (ChIP/luciferase), Sec23a rescue experiment in knockout chondrocytes, immunofluorescence, genetic epistasis |
Nature cell biology |
High |
19767744
|
| 2011 |
miR-200s directly target the 3'-UTR of SEC23A mRNA to suppress its expression, reducing secretion of metastasis-suppressive proteins Igfbp4 and Tinagl1 from the tumor cell secretome, thereby promoting metastatic colonization. |
3'-UTR reporter assay, proteomic/genomic analysis of secretome, functional rescue experiments in mouse breast cancer metastasis models |
Nature medicine |
High |
21822286
|
| 2011 |
miR-375 and miR-200c each target the 3'-UTR of SEC23A mRNA to downregulate SEC23A protein expression; ectopic overexpression of SEC23A in prostate cancer cell lines reduces cell growth without inducing apoptosis, while inhibition of SEC23A stimulates proliferation. |
3'-UTR luciferase reporter assay, Western blot, qRT-PCR, cell growth assays in LNCaP and DU145 cells |
Molecular cancer research : MCR |
Medium |
21593139
|
| 2013 |
ER stress impairs membrane association of COPII components, particularly Sec23a, reducing COPII vesicle formation at ER exit sites, and alters Sec23a cycling at ERESs. |
Fluorescence microscopy (ERES imaging), COPII vesicle formation assay, ER stress induction with pharmacological agents |
FEBS letters |
Medium |
23994533
|
| 2015 |
SEC23A-deficient mice exhibit mid-embryonic lethality with defective extraembryonic membrane development and neural tube opening; multiple collagen types accumulate intracellularly in SEC23A-deficient connective tissue cells, triggering unfolded protein response, while fibronectin secretion is unaffected, showing SEC23A preferentially transports collagen cargo. SEC23A and SEC23B transport overlapping but distinct cargo spectra in vivo. |
Sec23a knockout mouse, immunofluorescence, Western blot for secreted vs. intracellular collagen/fibronectin, UPR markers; Sec23a/Sec23b compound null analysis |
Scientific reports |
High |
26494538
|
| 2017 |
ULK1 phosphorylates SEC23A at serine 207, serine 312, and threonine 405; phosphorylation at S207 reduces the interaction between SEC23A and SEC31A, causes ERES aggregation, and inhibits ER-to-Golgi cargo transport during autophagy induction. |
In vitro kinase assay, site-directed mutagenesis (S207A/D, S312A/D, T405A/E), Co-immunoprecipitation (SEC23A–SEC31A interaction), live-cell imaging of ERES, cargo transport assays under amino acid starvation/rapamycin/ULK1 overexpression |
BMC cell biology |
High |
28486929
|
| 2017 |
Sec23a ubiquitylation occurs at non-canonical cysteine residues (C432 and C449) as mono-ubiquitin attachment; mutation of these sites affects Sec23a interaction with ER membrane and modulates COPII formation, without targeting Sec23a for degradation. |
Co-immunoprecipitation, mass spectrometry (Gly-Gly remnant identification), site-directed mutagenesis of C432 and C449, immunofluorescence |
The open biochemistry journal |
Medium |
28553408
|
| 2017 |
CREB3L2/BBF2H7 transcriptionally upregulates SEC23A (and SEC24D) expression during hepatic stellate cell (HSC) activation; knockdown of SEC23A abrogates HSC activation, establishing that SEC23A-mediated ER-to-Golgi trafficking is required for this differentiation process. |
siRNA knockdown, Western blot, RT-PCR, HSC activation assays |
Scientific reports |
Medium |
28801610
|
| 2018 |
SEC23A and SEC23B have indistinguishable intracellular protein interactomes; both complement yeast Sec23; a Sec23a coding sequence knocked into the Sec23b locus completely rescues the lethal SEC23B-deficient pancreatic phenotype in mice, demonstrating equivalent biochemical function with tissue-specific expression differences accounting for distinct phenotypes. |
Mass spectrometry interactome, yeast complementation, zebrafish transgene rescue, mouse knock-in (Sec23a coding sequence into Sec23b locus) |
Proceedings of the National Academy of Sciences of the United States of America |
High |
30065114
|
| 2018 |
Sec23a functions downstream of miR-200c to suppress oligometastatic-to-polymetastatic progression via its secretome; mass spectrometric analysis of secretory protein profiles shows Sec23a-dependent secretome modifies the tumor microenvironment. |
miR-200c overexpression/Sec23a knockdown in paired oligometastatic/polymetastatic melanoma lines, in vivo metastasis assays, mass spectrometry of secretome |
EBioMedicine |
Medium |
30301603
|
| 2020 |
S100A8 is transported by SEC23A (as COPII cargo) and inhibits metastatic colonization via autocrine activation of autophagy through a SEC23A–S100A8–BECLIN1–autophagy axis. |
SEC23A knockdown/overexpression, secretome analysis, autophagy assays (LC3, BECLIN1), paired oligometastatic/polymetastatic melanoma cell lines, in vivo colonization assays |
Cell death & disease |
Medium |
32811814
|
| 2021 |
SEC23A transports PF4 as COPII cargo; secreted PF4, cooperating with SPARC, inhibits melanoma metastasis through inhibition of the MAPK/ERK signaling pathway. |
SEC23A overexpression/knockdown in paired melanoma lines, secretome analysis, MAPK/ERK phosphorylation assays, in vivo metastasis assays |
International journal of biological sciences |
Medium |
34421345
|
| 2021 |
SEC23A expression is rescued in SEC23B-deficient HUDEP-2 human erythroid cells and reverses CDAII-like features upon differentiation, demonstrating functional interchangeability of the paralogs in human erythroid cells. |
CRISPR-generated SEC23B-deficient HUDEP-2 cells, SEC23A overexpression rescue, erythroid differentiation assays |
Science advances |
High |
34818036
|
| 2021 |
A monoallelic SEC23A E599K variant disrupts a residue predicted by 3D structural modeling to be involved in direct binding between SEC23 and SAR1 subunits of the COPII coat, suggesting dominant-negative disruption of the SEC23 multimer as the pathomechanism. |
Trio genome sequencing, familial segregation, 3D structural modeling of SEC23–SAR1 interface |
American journal of medical genetics. Part A |
Low |
34580982
|
| 2021 |
miR-1227 directly targets SEC23A (validated by luciferase assay); inhibition of SEC23A is sufficient to shift extracellular vesicle shedding toward large EVs (large oncosomes) and away from small EVs (exosomes). |
Luciferase 3'-UTR assay, qPCR, Western blot, SEC23A siRNA knockdown, EV size/population analysis |
Cancers |
Medium |
34831007
|
| 2022 |
SEC23A inhibits self-renewal of melanoma cancer stem cells by promoting ER stress and thereby inducing FAM134B-mediated ER-phagy; inhibition of SEC23A reduces ER stress and consequently suppresses FAM134B-induced ER-phagy, increasing stemness. |
Stable CSC cell lines from M14 and A375 melanoma, SEC23A knockdown/overexpression, LC3/P62 autophagy markers, transmission electron microscopy of ER morphology, spheroid formation and single-cell cloning assays, subcutaneous xenograft |
Cell communication and signaling : CCS |
Medium |
35236368
|
| 2023 |
SEC23A is transcriptionally upregulated by ER stress-induced pY705-STAT3; elevated SEC23A promotes autophagy by regulating cellular localization of ANXA2, and the SEC23A–ANXA2–autophagy axis protects gastric cancer cells from ER stress-induced apoptosis, creating a negative feedback loop. |
ChIP assay and luciferase reporter (STAT3 binding to SEC23A promoter), Co-immunoprecipitation and mass spectrometry (SEC23A–ANXA2 interaction), subcellular localization experiments, autophagy assays, in vitro and in vivo functional experiments |
Journal of experimental & clinical cancer research : CR |
Medium |
37670384
|
| 2012 |
The BBF2H7-mediated SEC23A pathway is required for ER-to-Golgi procollagen (COL1 and COL3) trafficking in dermal fibroblasts; BBF2H7 knockdown reduces collagen expression and causes Golgi dysmorphology due to COPII hypoplasia, phenotypes rescued by the pathway. |
siRNA knockdown of BBF2H7, immunofluorescence microscopy of Golgi and COPII, RT-PCR/Western blot for collagen expression, IGF-I stimulation assays |
The Journal of investigative dermatology |
Medium |
22495181
|
| 2012 |
TFII-I transcription factors (GTF2I/GTF2IRD1) are recruited to the promoter of SEC23A in human neural crest progenitor cells, identifying SEC23A as a direct TFII-I target gene. |
ChIP-chip (chromatin immunoprecipitation with tiling promoter arrays) in human neural crest progenitor cells |
The Cleft palate-craniofacial journal |
Low |
23145914
|
| 2026 |
Salidroside directly binds SEC23A (identified by DARTS assay and molecular docking); stress factors (Substance P/cortisol) specifically upregulate SEC23A, which salidroside suppresses; SEC23A knockdown potentiates salidroside's anti-melanogenic effects in the stress model via dual activation of the SEC23A–p-ERK–MITF axis and inhibition of NK1R–p38–MITF axis. |
DARTS (Drug Affinity Responsive Target Stability) assay, molecular docking, SEC23A siRNA knockdown, Western blot for p-ERK/MITF/p38, melanin content and tyrosinase activity assays, in vivo zebrafish and mouse models |
Pharmaceuticals (Basel, Switzerland) |
Medium |
41901332
|